1. FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer
   Jing Zhao et al, 2021, Biochemical Pharmacology CrossRef
2. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer
   Mingxuan Zhou et al, 2022, Frontiers in Immunology CrossRef
3. Fibroblast Growth Factor Receptor 4 Gly388Arg Gene Polymorphism and Non-Hodgkin Lymphoma Susceptibility and Prognosis in Egyptian population: Case–control Study
   Wafaa M. Abdelghany et al, 2021, Open Access Macedonian Journal of Medical Sciences CrossRef
4. ST6Gal1: Oncogenic signaling pathways and targets
   Sajina GC et al, 2022, Frontiers in Molecular Biosciences CrossRef
5. Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment
   Juanni Li et al, 2021, Aging CrossRef
6. Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives
   Ser John Lynon P. Perez et al, 2021, Molecules CrossRef
7. Aberrant Sialylation in Cancer: Therapeutic Opportunities
   Jennifer Munkley, 2022, Cancers CrossRef